Pediatrix Medical Group, Inc. (NYSE:MD) Shares Bought by Swiss National Bank

Swiss National Bank grew its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 168,900 shares of the company’s stock after purchasing an additional 4,600 shares during the quarter. Swiss National Bank owned approximately 0.20% of Pediatrix Medical Group worth $2,216,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Quest Partners LLC lifted its holdings in Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after purchasing an additional 622 shares in the last quarter. Everence Capital Management Inc. raised its position in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after buying an additional 960 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after buying an additional 1,040 shares during the last quarter. Quarry LP lifted its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after buying an additional 1,662 shares in the last quarter. Finally, AlphaQuest LLC boosted its position in Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after acquiring an additional 2,012 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

MD has been the topic of a number of research reports. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Macquarie began coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective on the stock. UBS Group raised their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Finally, Truist Financial boosted their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock opened at $15.06 on Friday. The firm has a market cap of $1.29 billion, a PE ratio of -12.55, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67. The business’s fifty day simple moving average is $14.39 and its 200-day simple moving average is $13.62.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. Equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.